SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-027223
Filing Date
2021-05-13
Accepted
2021-05-13 07:46:41
Documents
43
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q wve-10q_20210331.htm   iXBRL 10-Q 1194667
2 EX-10.2 wve-ex102_80.htm EX-10.2 62783
3 EX-10.3 wve-ex103_79.htm EX-10.3 60670
4 EX-31.1 wve-ex311_7.htm EX-31.1 14708
5 EX-31.2 wve-ex312_8.htm EX-31.2 14821
6 EX-32 wve-ex32_6.htm EX-32 8831
7 GRAPHIC guhsvx4e3cx1000001.jpg GRAPHIC 42320
  Complete submission text file 0001564590-21-027223.txt   3428002

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA wve-20210331.xsd EX-101.SCH 27495
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE wve-20210331_cal.xml EX-101.CAL 31385
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wve-20210331_def.xml EX-101.DEF 85189
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE wve-20210331_lab.xml EX-101.LAB 224032
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wve-20210331_pre.xml EX-101.PRE 157732
13 EXTRACTED XBRL INSTANCE DOCUMENT wve-10q_20210331_htm.xml XML 208828
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37627 | Film No.: 21917244
SIC: 2834 Pharmaceutical Preparations